IK Channel-Independent Effects of Clotrimazole and Senicapoc on Cancer Cells Viability and Migration

Paolo Zuccolini1, Raffaella Barbieri1, Francesca Sbrana1

  • 1Biophysics Institute, National Research Council, 16149 Genova, Italy.

Insights

IK channel blockers like clotrimazole and senicapoc reduced cancer cell viability and migration. These effects occurred regardless of IK channel expression, suggesting potential off-target actions in cancer therapy research.

Area of Science:

  • Oncology
  • Molecular Biology
  • Ion Channel Physiology

Background:

  • The IK channel (also known as KCNN4) is implicated in cancer cell proliferation and migration.
  • IK channel blockers have shown potential in slowing cancer growth.

Purpose of the Study:

  • To investigate the effects of IK blockers on melanoma and pancreatic cancer cells.
  • To determine if the anti-cancer effects of IK blockers are solely dependent on IK channel expression.

Main Methods:

  • Utilized two IK blockers: clotrimazole and senicapoc.
  • Tested on metastatic melanoma (WM266-4) and pancreatic cancer (Panc-1) cell lines.
  • Performed patch-clamp experiments to analyze ion channel activity and measured intracellular calcium levels.

Main Results:

  • Clotrimazole and senicapoc decreased viability and migration in both cell lines, irrespective of IK expression.
  • IK-like currents sensitive to the blockers were observed in WM266-4 cells but not Panc-1 cells.
  • Neither blocker affected intracellular calcium concentration.

Conclusions:

  • The anti-cancer effects of IK blockers may not strictly rely on plasma membrane IK channel presence.
  • Off-target effects on other cellular molecules or blockade of intracellular IK channels could explain the observed results.
  • Further research is needed to elucidate the precise mechanisms of IK blockers in cancer treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.7K